ADAMAS PHARMACEUTICALS INC - COM (ADMS) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q4 2021

Type / Class
Equity / COM
Symbol
ADMS
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ADAMAS PHARMACEUTICALS INC - COM (ADMS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2021 Q4 0 $0 -$147,117,087 0
2021 Q3 30,036,854 $147,613,092 -$1,400,460 $4.91 61
2021 Q2 30,309,421 $160,091,597 +$1,291,086 $5.28 63
2021 Q1 30,363,125 $145,726,725 +$70,382,551 $4.80 70
2020 Q4 14,272,645 $61,858,654 +$791,275 $4.33 62
2020 Q3 12,839,146 $52,894,323 +$777,772 $4.12 61
2020 Q2 13,092,265 $33,516,276 -$7,247,640 $2.56 60
2020 Q1 15,492,719 $44,773,190 -$2,891,415 $2.89 72
2019 Q4 16,383,735 $62,098,622 +$5,648,400 $3.79 77
2019 Q3 14,373,173 $73,514,237 -$17,296,559 $5.11 80
2019 Q2 17,602,131 $109,061,498 -$23,242,216 $6.20 73
2019 Q1 21,099,336 $150,032,843 -$27,096,974 $7.11 92
2018 Q4 24,224,296 $206,855,056 -$62,426,528 $8.54 95
2018 Q3 25,354,708 $507,648,169 -$14,529,623 $20.02 122
2018 Q2 26,182,272 $676,263,723 +$27,554,401 $25.83 125
2018 Q1 25,170,555 $601,550,047 +$93,559,826 $23.90 117
2017 Q4 20,704,201 $701,667,320 +$85,031,558 $33.89 117
2017 Q3 18,470,349 $390,961,417 +$59,681,282 $21.17 94
2017 Q2 15,772,038 $275,842,255 -$2,399,333 $17.49 77
2017 Q1 15,905,721 $278,346,543 +$19,010,580 $17.50 69
2016 Q4 16,135,078 $272,695,732 +$7,271,955 $16.90 78
2016 Q3 16,674,578 $273,630,528 +$10,336,320 $16.41 81
2016 Q2 16,068,523 $243,273,427 +$25,678,572 $15.14 81
2016 Q1 14,006,158 $202,495,000 +$34,326,454 $14.46 82
2015 Q4 11,199,754 $317,196,971 +$26,339,709 $28.32 93
2015 Q3 10,474,581 $175,338,501 -$2,019,228 $16.74 81
2015 Q2 10,253,784 $268,852,386 +$42,887,427 $26.22 87
2015 Q1 8,635,375 $151,013,353 +$33,598,520 $17.49 58
2014 Q4 11,299,676 $196,258,909 +$21,976,071 $17.37 51
2014 Q3 3,428,022 $63,711,296 +$5,692,103 $18.62 43
2014 Q2 3,117,938 $56,995,933 +$56,990,933 $18.28 37